{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:54:25Z","timestamp":1783612465363,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173581"],"award-info":[{"award-number":["82173581"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373650"],"award-info":[{"award-number":["82373650"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["202340298"],"award-info":[{"award-number":["202340298"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jinf.2025.106648","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:03:09Z","timestamp":1761930189000},"page":"106648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between pre-diagnostic fluoroquinolone exposure and possible acquired fluoroquinolone resistance in Mycobacterium tuberculosis in Shanghai: An EHR-based case-control study using whole-genome sequencing"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0793-8934","authenticated-orcid":false,"given":"Yangyi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5595-9138","authenticated-orcid":false,"given":"Danni","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2025.106648_bib1","unstructured":"World Health Organization. Global tuberculosis report 2024 [Internet]. Geneva; 2024. Available from: https:\/\/iris.who.int\/handle\/10665\/379339. [Accessed May 1, 2025]."},{"issue":"6","key":"10.1016\/j.jinf.2025.106648_bib2","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/jac\/40.6.885","article-title":"In-vitro activity of fluorinated quinolones and macrolides against drug-resistant Mycobacterium tuberculosis","volume":"40","author":"Hoffner","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2025.106648_bib3","unstructured":"World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva; 2019."},{"issue":"17","key":"10.1016\/j.jinf.2025.106648_bib4","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1407426","article-title":"Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis","volume":"371","author":"Gillespie","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jinf.2025.106648_bib5","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/jac\/dkw013","article-title":"Trends and patterns of antibiotic consumption in Shanghai municipality, China: a 6 year surveillance with sales records, 2009\u201314","volume":"71","author":"Lin","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2025.106648_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.757309","article-title":"Trends and patterns of antibiotics use in China's urban tertiary hospitals, 2016\u201319","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.jinf.2025.106648_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijantimicag.2011.11.015","article-title":"Commentary on: Does empirical treatment of community-acquired pneumonia with fluoroquinolones delay tuberculosis treatment and result in fluoroquinolone resistance in Mycobacterium tuberculosis? Controversies and solutions","volume":"39","author":"Hara","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"10.1016\/j.jinf.2025.106648_bib8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1183\/09031936.00019915","article-title":"Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study","volume":"46","author":"Wang","year":"2015","journal-title":"Eur Respir J"},{"issue":"20","key":"10.1016\/j.jinf.2025.106648_bib9","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1056\/NEJM200311133492023","article-title":"The rapid development of fluoroquinolone resistance in M. tuberculosis","volume":"349","author":"Ginsburg","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2025.106648_bib10","article-title":"Whole-genome sequencing for surveillance of fluoroquinolone resistance in rifampicin-susceptible tuberculosis in a rural district of Shanghai: a 10-year retrospective study","volume":"10","author":"Zhang","year":"2022","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.jinf.2025.106648_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2302837","article-title":"Transmission of fluoroquinolones resistance among multidrug-resistant tuberculosis in Shanghai, China: a retrospective population-based genomic epidemiology study","volume":"13","author":"Li","year":"2024","journal-title":"Emerg Microbes Infect"},{"issue":"5","key":"10.1016\/j.jinf.2025.106648_bib12","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/amiajnl-2013-002001","article-title":"Electronic recording and reporting system for tuberculosis in China: experience and opportunities","volume":"21","author":"Huang","year":"2014","journal-title":"J Am Med Inf Assoc"},{"issue":"7","key":"10.1016\/j.jinf.2025.106648_bib13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S1473-3099(18)30218-4","article-title":"Internal migration and transmission dynamics of tuberculosis in Shanghai, China: an epidemiological, spatial, genomic analysis","volume":"18","author":"Yang","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2025.106648_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13073-019-0650-x","article-title":"Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs","volume":"11","author":"Phelan","year":"2019","journal-title":"Genome Med"},{"issue":"12","key":"10.1016\/j.jinf.2025.106648_bib15","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/infdis\/jiv011","article-title":"Reemergence and amplification of tuberculosis in the Canadian arctic","volume":"211","author":"Lee","year":"2015","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2025.106648_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1473-3099(12)70277-3","article-title":"Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study","volume":"13","author":"Walker","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2025.106648_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002137","article-title":"Whole genome sequence analysis of a large isoniazid-resistant tuberculosis outbreak in london: a retrospective observational study","volume":"13","author":"Casali","year":"2016","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.jinf.2025.106648_bib18","first-page":"410","article-title":"Expert consensus on off-label use of antimicrobial agents","volume":"38","author":"Professional Committee on Infectious Diseases CMEAC","year":"2015","journal-title":"Chin J Tuberc Respir Dis"},{"issue":"10","key":"10.1016\/j.jinf.2025.106648_bib19","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S1473-3099(16)30190-6","article-title":"Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project","volume":"16","author":"Zignol","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2025.106648_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02170-16","article-title":"Genotyping and prevalence of pyrazinamide- and moxifloxacin-resistant tuberculosis in China, 2000 to 2010","volume":"61","author":"Pang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2025.106648_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1413618","article-title":"Surveillance of fluoroquinolones resistance in rifampicin-susceptible tuberculosis in eastern China with whole-genome sequencing-based approach","volume":"15","author":"Che","year":"2024","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.jinf.2025.106648_bib22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/jac\/dkq465","article-title":"Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection","volume":"66","author":"van der Starre","year":"2011","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.jinf.2025.106648_bib23","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/jac\/dkq351","article-title":"Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital","volume":"65","author":"Gallini","year":"2010","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jinf.2025.106648_bib24","first-page":"77","article-title":"Use of fluoroquinolone antibiotics leads to tuberculosis treatment delay in a South African gold mining community","volume":"15","author":"Jeon","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.jinf.2025.106648_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5152\/TurkThoracJ.2021.19128","article-title":"The relation between the emergence of fluoroquinolone resistance and fluoroquinolone exposure in new cases of active pulmonary tuberculosis","volume":"22","author":"Ayd\u0131n Kayal\u0131","year":"2021","journal-title":"Turk Thorac J"},{"issue":"3","key":"10.1016\/j.jinf.2025.106648_bib26","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.ijid.2010.11.008","article-title":"Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis","volume":"15","author":"Chen","year":"2011","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2025.106648_bib27","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1183\/09031936.00036812","article-title":"Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones","volume":"40","author":"Migliori","year":"2012","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.jinf.2025.106648_bib28","first-page":"217","article-title":"Fluoroquinolone resistance in renal isolates of Mycobacterium tuberculosis","volume":"14","author":"Webster","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.jinf.2025.106648_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/emph\/eot003","article-title":"Epistasis between antibiotic resistance mutations drives the evolution of extensively drug-resistant tuberculosis","volume":"2013","author":"Borrell","year":"2013","journal-title":"Evol Med Public Health"},{"issue":"7","key":"10.1016\/j.jinf.2025.106648_bib30","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ng.2656","article-title":"Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis","volume":"45","author":"Ford","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.jinf.2025.106648_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/molbev\/msz214","article-title":"The genetic background modulates the evolution of fluoroquinolone-resistance in Mycobacterium tuberculosis","volume":"37","author":"Castro","year":"2020","journal-title":"Mol Biol Evol"},{"issue":"10","key":"10.1016\/j.jinf.2025.106648_bib32","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1086\/598196","article-title":"Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuberculosis","volume":"48","author":"Long","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2025.106648_bib33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1164\/rccm.200901-0146OC","article-title":"Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure","volume":"180","author":"Devasia","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2025.106648_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijid.2013.09.013","article-title":"Community-acquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones","volume":"18","author":"Grossman","year":"2014","journal-title":"Int J Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2025.106648_bib35","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/thx.2005.056887","article-title":"Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas","volume":"61","author":"Wang","year":"2006","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.jinf.2025.106648_bib36","first-page":"319","article-title":"Impact of short-term exposure to fluoroquinolones on ofloxacin resistance in HIV-negative patients with tuberculosis","volume":"11","author":"Park","year":"2007","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325002488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445325002488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T19:21:39Z","timestamp":1773861699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445325002488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0163445325002488"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106648","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between pre-diagnostic fluoroquinolone exposure and possible acquired fluoroquinolone resistance in Mycobacterium tuberculosis in Shanghai: An EHR-based case-control study using whole-genome sequencing","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2025.106648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106648"}}